Stock scanner
Ready-made scans
Fastest expected revenue growth under $2BCheap and profitableDividend payersNear their 52-week highBeaten down, finances improvingReporting this week
Filters
5,450 US-listed companies, filtered by valuation, profitability, growth, analysts' forecasts and momentum. Prices are from the October 9 close; company figures refresh weekly.
This data is 9 days old: the nightly update hasn't run since October 10.
The scanner turns your question into filters, and the results come straight from the data. The filters it chose show below, to check or change. You get 3 free questions a month.
5,450 companies match
| Company | Mkt cap | Price | P/E | EV/Sales | P/B | Yield | Net margin | ROIC | Rev growth | 1Y |
|---|---|---|---|---|---|---|---|---|---|---|
| EPOWE-Power Inc. Class A | $4M | $3.28 | loss | 1.4 | — | 0.0% | −35.8% | −16.5% | −28.6% | −89.5% |
| WXMWF International Limited Ordinary Shares | $4M | $3.42 | loss | 0.3 | 51.0 | 0.0% | −24.5% | −34.6% | −13.7% | −89.8% |
| AMTDAMTD IDEA Group | $4M | $0.51 | — | n/a | — | 0.0% | 72.4% | n/a | 5.8% | −53.1% |
| MTRMesa Royalty Trust | $4M | $2.09 | 11.2 | 3.4 | 1.2 | 7.2% | 68.7% | 10.5% | 0.1% | −58.9% |
| APVOAptevo Therapeutics Inc. | $4M | $1.79 | loss | — | 0.4 | 0.0% | — | −262% | — | −93.7% |
| ERNAErnexa Therapeutics Inc. | $4M | $2.40 | loss | — | 0.9 | 0.0% | — | −328% | −100% | −92.6% |
| VMARVision Marine Technologies Inc. | $4M | $6.07 | loss | 0.5 | — | 0.0% | −34.2% | −34.5% | 3941% | −99.9% |
| ADXNAddex Therapeutics Ltd | $4M | $3.22 | loss | 42.0 | 2.0 | 0.0% | −10875% | −120% | −48.1% | −65.9% |
| XPONExpion360 Inc. | $4M | $4.16 | loss | 0.4 | 0.8 | 0.0% | −82.3% | −204% | −2.4% | −74.7% |
| CYCUCycurion, Inc. Common Stock | $4M | $2.97 | loss | 0.7 | 0.1 | 0.0% | −98.0% | −49.2% | −11.6% | −95.1% |
| HIHOHighway Holdings Limited | $4M | $0.86 | loss | 0.6 | 0.8 | 5.8% | −28.1% | −17.8% | −25.7% | −48.5% |
| CALCCalciMedica, Inc. | $4M | $1.27 | loss | — | 0.8 | 0.0% | — | −123% | — | −92.0% |
| HYFMHydrofarm Holdings Group, Inc. | $4M | $0.84 | loss | 1.5 | neg. eq. | 0.0% | −267% | −42.1% | −34.1% | −74.4% |
| EEIQElite Education Group International Limited | $4M | $4.91 | loss | 0.6 | 1.0 | 0.0% | −51.1% | −29.9% | 9.6% | −28.6% |
| TAOPTaoping Inc. | $4M | $0.42 | loss | 0.4 | 0.0 | 0.0% | −32.6% | −31.4% | −16.0% | −85.6% |
| YCBDcbdMD, Inc. | $4M | $0.39 | loss | 0.2 | 0.5 | 0.0% | −13.8% | −27.9% | 10.0% | −68.3% |
| DRMADermata Therapeutics, Inc. | $4M | $1.02 | loss | — | 1.2 | 0.0% | — | −247% | — | −75.4% |
| PCSAProcessa Pharmaceuticals, Inc. | $4M | $1.52 | loss | — | neg. eq. | 0.0% | — | 4052% | — | −83.9% |
| EJHE-Home Household Service Holdings Limited | $4M | $1.33 | loss | — | — | 0.0% | 8.2% | −1.0% | −2.1% | −94.8% |
| ENLVEnlivex Therapeutics Ltd. | $4M | $0.25 | — | — | — | 0.0% | — | −0.3% | — | −98.5% |
| MKDWMKDWELL Tech Inc. | $4M | $1.02 | loss | 0.4 | 0.7 | 0.0% | −84.9% | −21.7% | 51.6% | −84.3% |
| PMCBPharmaCyte Biotech, Inc. | $4M | $0.40 | loss | — | 0.1 | 0.0% | — | −19.5% | — | −59.6% |
| CWDCaliberCos Inc. | $4M | $0.51 | loss | 10.9 | — | 0.0% | −155% | −29.9% | −61.9% | −87.3% |
| HXHXHaoxin Holdings Limited Class A Ordinary Shares | $4M | $0.32 | 7.9 | 3.2 | 0.2 | 0.0% | 12.0% | 1.9% | 29.2% | −73.8% |
| GAUZGauzy Ltd. Ordinary Shares | $4M | $4.70 | loss | 1.6 | 0.2 | 0.0% | −50.7% | −24.5% | 7.9% | −96.5% |
| RENXRenX Enterprises Corp. | $4M | $1.67 | loss | 1.5 | 0.6 | 0.0% | −169% | −25.4% | 877% | −91.9% |
| GXAIGaxos.ai Inc. | $4M | $0.43 | loss | 0.6 | 0.3 | 0.0% | −64.8% | −42.6% | 2922% | −76.1% |
| TCToken Cat Limited | $5M | $1.55 | loss | 1.0 | — | 0.0% | −3.4% | −25.1% | −88.3% | −89.3% |
| CUPRCuprina Holdings (Cayman) Limited Class A Ordinary Shares | $5M | $1.69 | loss | 63.2 | 1.1 | 0.0% | −9367% | −82.5% | 3.3% | −78.0% |
| IMNNImunon, Inc. | $5M | $1.08 | loss | — | 1.3 | 0.0% | — | −122% | — | −78.7% |
| CLGNCollPlant Biotechnologies Ltd. | $5M | $3.51 | loss | 7.6 | 1.0 | 0.0% | −3376% | −172% | −84.3% | −84.0% |
| AIDX20/20 Biolabs Inc. | $5M | $0.38 | loss | 0.3 | 1.3 | 0.0% | −285% | −117% | 16.7% | −98.4% |
| FAMIFarmmi, Inc. | $5M | $0.12 | loss | 1.2 | — | 0.0% | −495% | −62.2% | −56.4% | −92.8% |
| BGMSBio Green Med Solution, Inc. | $5M | $0.85 | loss | 0.5 | 0.7 | 0.0% | −118% | −38.2% | 18510% | −83.5% |
| FBGLFBS Global Limited Ordinary Shares | $5M | $3.48 | — | 2.2 | neg. eq. | 0.0% | −7.9% | −14.8% | 86.8% | −47.5% |
| CXAICXApp Inc. | $5M | $2.16 | loss | 1.0 | 0.1 | 0.0% | −582% | −52.1% | −39.0% | −94.8% |
| JBDIJBDI Holdings Limited | $5M | $1.00 | 23.8 | 0.4 | 2.4 | 0.0% | 2.1% | −2.5% | — | −74.7% |
| YDKGYueda Digital Holding, Inc. | $5M | $0.86 | loss | 0.1 | — | 0.0% | −235% | −22.0% | 8107% | −99.6% |
| GELSGelteq Limited Ordinary Shares | $5M | $0.52 | loss | 66.7 | 0.5 | 0.0% | −2095% | −18.3% | — | −59.9% |
| AGRZAgroz Inc. Ordinary Shares | $5M | $4.42 | 120 | 9.7 | 31.2 | 0.0% | 8.6% | 17.7% | 121% | −96.1% |
| KNRXKnorex Ltd. | $5M | $0.19 | loss | 3.7 | neg. eq. | 0.0% | −216% | −954% | −44.2% | −92.0% |
| XBIOXenetic Biosciences, Inc. | $5M | $2.13 | loss | — | 0.8 | 0.0% | −75.9% | −43.5% | 33.3% | −66.4% |
| SNTGSentage Holdings Inc. | $5M | $1.74 | loss | 89.1 | 0.6 | 0.0% | −3305% | −23.0% | −35.9% | −41.6% |
| BIYABaiya International Group Inc. | $5M | $1.83 | loss | 0.4 | — | 0.0% | −72.3% | −25.7% | 28.6% | −98.6% |
| DDCDDC Enterprise Limited | $5M | $0.20 | loss | 2.3 | — | 0.0% | −130% | −19.0% | 0.3% | −97.7% |
| SCKTSocket Mobile, Inc. | $5M | $0.60 | loss | 0.8 | 2.1 | 0.0% | −108% | −35.0% | −17.4% | −36.6% |
| NVNINvni Group Limited Ordinary Shares | $5M | $0.53 | loss | 0.4 | neg. eq. | 0.0% | −36.9% | −35.0% | 1.8% | −82.8% |
| CHNRChina Natural Resources, Inc. | $5M | $3.99 | loss | — | 0.4 | 0.0% | — | −1.4% | — | −19.9% |
| LIMNLiminatus Pharma, Inc. Class A Common Stock | $5M | $3.76 | loss | — | 5.9 | 0.0% | — | −225% | — | −94.7% |
| ORKTOrangekloud Technology Inc. | $5M | $1.01 | loss | 0.9 | 0.9 | 0.0% | −77.7% | −72.3% | 38.3% | −50.2% |
Showing 301–350 of 5,450
A blank means a figure isn't reported or doesn't mean anything for that company: there's no P/E for a company losing money, no EV/Sales for a bank, no P/B when a company owes more than it owns. A filter on that figure leaves the company out. Growth compares the last twelve months with the twelve before. Figures describe the companies; they aren't advice to buy or sell anything.